Testosterone Undecanoate 750 MG/3 ML Intramuscular Solution [AVEED] for Testicular Hypogonadism
Study Summary
This trial will evaluate the effect of testosterone on fatigue, sexual function, quality of life, body composition, muscle strength, and physical activity in young cancer survivors.
- Testicular Hypogonadism
- Chronic Fatigue Syndrome
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Awards & Highlights
Trial Design
Find a site
Who is running the clinical trial?
Media Library
Frequently Asked Questions
Could you please elaborate on the potential side effects of Testosterone Undecanoate 750 MG/3 ML Intramuscular Solution [AVEED]?
"While there is some data backing the safety of Testosterone Undecanoate, this medication has yet to be proven effective and thus receives a score of 2."
Are we recruiting participants for this trial at this time?
"Yes, this is an active recruitment as indicated by the most recent update on 8/11/2022. The listing was first posted by the sponsor on 3/22/2021."
How many participants are involved in this experiment?
"Yes, this is an active trial that is currently recruiting patients. The primary recruitment sites are in New York and Miami. To date, 240 individuals have signed up for the study."
Are there other ongoing trials with Testosterone Undecanoate 750 MG/3 ML Intramuscular Solution [AVEED]?
"Testosterone Undecanoate 750 MG/3 ML Intramuscular Solution [AVEED] was first studied in 2019 at Brigham and Women's Hospital. Since then, there have been 2721 completed studies. Currently, 8 active trials are underway, a majority of which are taking place in Seattle, Washington."
Can elderly citizens participate in this research?
"Eligible participants for this clinical trial must be between 18 and 54 years old. In contrast, there are 14 other clinical trials that focus on children and 205 that focus on adults over the age of 65."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- Veterans Affairs Puget Sound Health Care System: < 24 hours
- Brigham and Women's Hospital: < 48 hours
Average response time
- < 2 Days